Jiangsu, China

Maoqiong Pan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maoqiong Pan. Retrieved from https://idiyas.com/inventor/maoqiong-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maoqiong Pan: Innovator in Cancer Treatment

Introduction

Maoqiong Pan is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. His innovative work focuses on developing effective therapeutic agents for serious health conditions.

Latest Patents

Maoqiong Pan holds a patent for a quinoline derivative aimed at treating nasopharyngeal carcinoma. This invention provides a novel approach to combat this type of cancer and is intended for use in the preparation of pharmaceutical compositions for tumor treatment. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Maoqiong Pan is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His role in this organization allows him to contribute to the development of innovative treatments that can improve patient outcomes.

Collaborations

Maoqiong Pan has worked alongside talented colleagues such as Shanchun Wang and Jun Shen. Their collaborative efforts enhance the research and development processes within their organization.

Conclusion

Maoqiong Pan's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…